Skip to main content

Advertisement

Log in

Clinical Outcomes in Newer Anticonvulsant Overdose: A Poison Center Observational Study

  • Investigation
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Clinicians have limited experience with assessment and treatment of overdose from newer anticonvulsant medications. The aim of this investigation was to evaluate clinical effects of newer anticonvulsant overdose, determine if a relationship exists between dose and clinical effect, and if a particular agent appears more toxic in overdose. This was a retrospective study using electronic poison center data, evaluating clinical outcomes from newer anticonvulsant overdose. The Toxicall™ database from January 1, 2002 to December 31, 2011 was queried using key words: “gabapentin,” “lamotrigine,” “levetiracetam,” “tiagabine,” “topiramate,” “zonisamide,” “pregabalin,” and “oxcarbazine.” Polypharmacy overdose and children less than 15 years of age were excluded. Charts were reviewed by two abstractors for pharmaceutical, self-reported dose, clinical effect score, and clinical signs, symptoms, and vital signs recorded in the chart. Ordinal logistic regression was used to evaluate the relationship between drug type, dose, age, and sex to clinical effect score. Out of 501 cases identified, 347 met the final inclusion criteria. There were 116 gabapentin, 67 lamotrigine, 15 levetiracetam, 15 tiagabine, 56 topiramate, 23 pregabalin, and 55 oxcarbazepine cases. Overdose of newer anticonvulsants frequently results in altered mental status. Seizures may be more common with tiagabine, lamotrigine, and oxcarbazepine. There was one death reported from intentional overdose of topiramate. An information index was created to rank drug toxicity based on reported signs and symptoms for each overdose. There was no significant effect of dose on severity of outcome (β = 0.12, p = 0.23). However, the risk of a more severe outcome score was significantly increased with tiagabine relative to other drugs (β = 2.8, p = 0.001). Lamotrigine ranked highest in terms of toxicity (HT = 1.66) and number of interventions performed (HI = 1.17), and levetiracetam the lowest (HT = 0.98; HI = 0.88). We could not identify a dose-effect in these data which likely reflects the limitations of self-reported doses. Despite limitations of these data, the risk of more severe outcome scores appear to be higher with tiagabine overdose while lamotrigine overdose appears to result in more reported signs, symptoms, and interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Allison, P. D., & Safari books online. (2012). Logistic regression using SAS (2nd ed.). Cary, NC: SAS Pub

  2. Anand JS, Chodorowski Z, Wisniewski M (2007) Seizures induced by topiramate overdose. Clin Toxicol (Phila) 45(2):197

    Article  Google Scholar 

  3. Awaad Y (2007) Accidental overdosage of levetiracetam in two children caused no side effects. Epilepsy Behav 11(2):247

    Article  PubMed  Google Scholar 

  4. Barrueto F Jr, Williams K, Howland MA, Hoffman RS, Nelson LS (2002) A case of levetiracetam (keppra) poisoning with clinical and toxicokinetic data. J Toxicol Clin Toxicol 40(7):881–884

    Article  PubMed  Google Scholar 

  5. Bauer J, Cooper-Mahkorn D (2008) Tiagabine: efficacy and safety in partial seizures—current status. Neuropsychiatr Dis Treat 4(4):731–736

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Bodmer M, Monte AA, Kokko J, Yin S (2011) Safety of non-therapeutic levetiracetam ingestions—a poison center based study. Pharmacoepidemiol Drug Saf 20(4):366–369. doi:10.1002/pds.2113

    Article  CAS  PubMed  Google Scholar 

  7. Braga AJ, Chidley K (2007) Self-poisoning with lamotrigine and pregabalin. Anaesthesia 62(5):524–527

    Article  CAS  PubMed  Google Scholar 

  8. Brar B, Glazer JP, Franco K, Edwards T (2005) Acute mental status changes with topiramate. J Am Acad Child Adolesc Psychiatry 44(8):725

    Article  PubMed  Google Scholar 

  9. Briassoulis G, Kalabalikis P, Tamiolaki M, Hatzis T (1998) Lamotrigine childhood overdose. Pediatr Neurol 19(3):239–242

    Article  CAS  PubMed  Google Scholar 

  10. Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC (2012) 2011 annual report of the american association of poison control centers' national poison data system (NPDS): 29th annual report. Clin Toxicol (Phila, Pa) 50(10):911–1164. doi:10.3109/15563650.2012.746424

    Article  Google Scholar 

  11. Buckley NA, Whyte IM, Dawson AH (1993) Self-poisoning with lamotrigine. Lancet 342(8886–8887):1552–1553

    Article  CAS  PubMed  Google Scholar 

  12. Chung AM, Reed MD (2004) Intentional topiramate ingestion in an adolescent female. Ann Pharmacother 38(9):1439–1442

    Article  PubMed  Google Scholar 

  13. Dinnerstein E, Jobst BC, Williamson PD (2007) Lamotrigine intoxication provoking status epilepticus in an adult with localization-related epilepsy. Arch Neurol 64(9):1344–1346

    Article  PubMed  Google Scholar 

  14. Fleurat M, Smollin C (2012) Case files of the University of California San Francisco medical toxicology fellowship: lamotrigine toxicity. J Med Toxicol: Off J Am Coll Med Toxicol 8(1):52–58. doi:10.1007/s13181-012-0210-x

    Article  Google Scholar 

  15. Herold TJ (2006) Lamotrigine as a possible cause of QRS prolongation in a patient with known seizure disorder. Cjem 8(5):361–364

    PubMed  Google Scholar 

  16. Jette N, Cappell J, VanPassel L, Akman CI (2006) Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy. Neurology 67(8):1514–1515

    Article  PubMed  Google Scholar 

  17. Jones H, Aguila E, Farber HW (2002) Gabapentin toxicity requiring intubation in a patient receiving long-term hemodialysis. Ann Intern Med 137(1):74

    Article  PubMed  Google Scholar 

  18. Klein-Schwartz W, Shepherd JG, Gorman S, Dahl B (2003) Characterization of gabapentin overdose using a poison center case series. J Toxicol Clin Toxicol 41(1):11–15

    Article  CAS  PubMed  Google Scholar 

  19. Larson DA (1992) Analysis of variance with just summary statistics as input. Am Stat 46(2):151–152. doi:10.1080/00031305.1992.10475872

    Google Scholar 

  20. Lin G, Lawrence R (2006) Pediatric case report of topiramate toxicity. Clin Toxicol (Phila) 44(1):67–69

    Article  Google Scholar 

  21. Lofton AL, Klein-Schwartz W (2004) Evaluation of lamotrigine toxicity reported to poison centers. Ann Pharmacother 38(11):1811–1815

    Article  CAS  PubMed  Google Scholar 

  22. Lofton AL, Klein-Schwartz W (2005) Evaluation of toxicity of topiramate exposures reported to poison centers. Hum Exp Toxicol 24(11):591–595

    Article  CAS  PubMed  Google Scholar 

  23. Magurran AE (1988) Ecological diversity and its measurement. Princeton University Press; Croom Helm, Princeton

    Book  Google Scholar 

  24. O'Donnell J, Bateman DN (2000) Lamotrigine overdose in an adult. J Toxicol Clin Toxicol 38(6):659–660

    Article  PubMed  Google Scholar 

  25. Ostrovskiy D, Spanaki MV, Morris GL 3rd (2002) Tiagabine overdose can induce convulsive status epilepticus. Epilepsia 43(7):773–774

    Article  PubMed  Google Scholar 

  26. Reimers A, Reinholt G (2007) Acute lamotrigine overdose in an adolescent. Ther Drug Monit 29(5):669–670

    Article  PubMed  Google Scholar 

  27. Schwartz MD, Geller RJ (2007) Seizures and altered mental status after lamotrigine overdose. Ther Drug Monit 29(6):843–844

    Article  PubMed  Google Scholar 

  28. Thundiyil JG, Kearney TE, Olson KR (2007) Evolving epidemiology of drug-induced seizures reported to a poison control center system. J Med Toxicol 3(1):15–19

    Article  PubMed Central  PubMed  Google Scholar 

  29. Verma A, St Clair EW, Radtke RA (1999) A case of sustained massive gabapentin overdose without serious side effects. Ther Drug Monit 21(6):615–617

    Article  CAS  PubMed  Google Scholar 

  30. Wade JF, Dang CV, Nelson L, Wasserberger J (2010) Emergent complications of the newer anticonvulsants. J Emerg Med 38(2):231–237. doi:10.1016/j.jemermed.2008.03.032

    Article  PubMed  Google Scholar 

  31. Wax PM, Kleinschmidt KC, Brent J, ACMT ToxIC case registry investigators (2011) The toxicology investigators consortium (ToxIC) registry. J Med Toxicol: Off J Am Coll Med Toxicol 7(4):259–265. doi:10.1007/s13181-011-0177-z

    Article  CAS  Google Scholar 

  32. Wisniewski M, Lukasik-Glebocka M, Anand JS (2009) Acute topiramate overdose—clinical manifestations. Clin Toxicol (Phila) 47(4):317–320

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brandon Wills.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wills, B., Reynolds, P., Chu, E. et al. Clinical Outcomes in Newer Anticonvulsant Overdose: A Poison Center Observational Study. J. Med. Toxicol. 10, 254–260 (2014). https://doi.org/10.1007/s13181-014-0384-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-014-0384-5

Keywords

Navigation